5/31/98

Bibliography for Nicotine Dependence

Compiled by Alison Jones, MD

Overviews
Schuckit MA Drug and Alcohol Abuse 4th edition, Chap. 1 2:259-269.Plenum Publishing Corp. New York, NY.c. 1995

Galanter M. Kleber HD. American Psychiatric Press Textbook of Substance Abuse Treatment, Chap. 11: 1 57-177.    American Psychiatric Association Press. Washington D.C. c.1994

Lowinsen JH. Ruiz P. MilIman R. Langrod JG. Substance Abuse: A Comprehensive Textbook 3rd edition, Chap.25: 276-294. Williams & Wilkins. Baltimore, ML. c. 1997

Epidemiology and biobehavioral effects

Pomerleau OF. Nicotine and the central nervous system: biobehavioral effects of cigarette smoking. (Review] [1 5 refs] American Journal of Medicine. 93(1A):2S-7S, 1992 Jul 15.

Hughes JR. Gust SW. Pechacek TF. Prevalence of tobacco dependence and withdrawal. American Journal of Psychiatry. 144(2):205-8, 1987 Feb.

Benowitz NL Pharmacology of nicotine: addiction and therapeutics. Annu Rev Pharmacol Toxicol. 1996;36:597-613

Smoking Cessation (General)

Terres W. Becker P. Rosenberg A. Changes in cardiovascular risk profile during the cessation of smoking. American Journal of Medicine. 97(3):242-9, 1994 Sep.

Lifrak P. Gariti P. Alterman Al. McKay J. Volpicelli J. Sparkman T. OBrien C. Results of two levels of adjunctive treatment used with the nicotine patch. American Journal on Addictions. 6(2):93-8, 1997 Spring.

Anonymous. Practice guideline for the treatment of patients with nicotine dependence. American Psychiatric Association. [Review] [219 refs] American Journal of Psychiatry. 153(10 Suppl):1-31, 1996 Oct.

Benowitz NL. Treating tobacco addiction--nicotine or no nicotine? (editorial; comment]. Comments; Comment on: N EngI J Med 1997 Oct 23;337(17):1 195-202 New England Journal of Medicine. 337(17):1230-1, 1997 Oct 23.

Skaar K. Tsoh J. Cinciripini P. Wetter D. Prokhorov A. Gritz E. Current approaches in smoking cessation. (Review] (19 refs] Current Opinion in Oncology. 8(5):434-40, 1996 Sep. NICOTINE DELIVERY SYSTEMS

Homsy W. Yan K. Houle JM. Besner JG. Gossard D. Pierce CH. Caille G. Plasma levels of nicotine and safety of smokers wearing transdermaldelivery systems during multiple simultaneous intake of nicotine and during exercise. Journal of Clinical Pharmacology. 37(8):728-36, 1997 Aug.

Gupta SK. Hwang SS. Causey D. RoIf CN. Gorsline J. Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking. Journal of Clinical Pharmacology. 35(10):985-9, 1995 Oct.

Gupta SK. Okerholm RA. Eller M. Wei G. RoIf CN. Gorsline J. Comparison of the pharmacokinetics of two nicotine transdermal systems: nicoderm and habitrol. Journal of Clinical Pharmacology. 35(5):493-8, 1995 May.

Hilleman DE. Mohiuddin SM. Delcore MG. Comparison of fixed-dose transdermal nicotine, tapered-dose transdermal nicotine, and buspirone in smoking cessation. Journal of Clinical Pharmacology. 34(3):222-4, 1994 Mar.

Gupta SK. Okerholm RA. Coen P. Prather RD. Gorsline J. Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System). Journal of Clinical Pharmacology. 33(2):169-74, 1993 Feb.

Gorsline J. Gupta SK. Dye 0. RoIf CN. Steady-state pharmacokinetics and dose relationship of nicotine delivered from Nicoderm (Nicotine Transdermal System). Journal of Clinical Pharmacology. 33(2):161 -8, 1993 Feb.

Homsy W. Yan K. Houle JM. Besner JG. Gossard D. Pierce CH. Caille G. Plasma levels of nicotine and safety of smokers wearing transdermal delivery systems during multiple simultaneous intake of nicotine and during exercise. Journal of Clinical Pharmacology. 37(8):728-36, 1997 Aug.

Schneider NG. Popek P. Jarvik ME. Gritz ER. The use of nicotine gum during cessation of smoking. American Journal of Psychiatry. 1 34(4):439-40, 1977 Apr

Goldstein MG. Bupropion sustained release and smoking cessation. (Review] [40 refs] Journal of Clinical Psychiatry. 59 Suppl 4:66-72, 1998.

Jackson EA. Bupropion for smoking cessation. Journal of Family Practice. 46(2):1 11-2, 1998 Feb.

Pasternak M.Sustained-release bupropion for smoking cessation [letter]. New England Journal of Medicine. 338(9):61 9-20, 1998 Feb 26.

Sutherland G. Stapleton JA. Russell MA. Jarvis MJ. Hajek P. Belcher M.     Feyerabend C. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet. 340(8815):324-9, 1992 Aug 8.

Hurt RD. Sachs DP. Glover ED. Offord KP. Johnston JA. Dale LC. Khayrallah MA. Schroeder DR. Glover PN. Sullivan CR. Croghan IT. Sullivan PM. A comparison of sustained-release bupropion and placebo for smoking cessation (see comments]. Comments Comment in: N EngI J Med 1997 Oct 23;337(17):1230-1

Comorbidity
Covey LS. Glassman AH. Stetner F. Major depression following smoking cessation. American Journal of Psychiatry. 1 54(2):263-5, 1997 Feb.

Adler LE. Hoffer LD. Wiser A. Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. American Journal of Psychiatry. 150(1 2):1 856-61, 1993 Dec.

Lief HI. Bupropion treatment of depression to assist smoking cessation (letter]. American Journal of Psychiatry. 1 53(3):442, 1996 Mar.

Campbell BK. Wander N. Stark MJ. Holbert T. Treating cigarette smoking in drug-abusing clients. Journal of Substance Abuse Treatment. 1 2(2):89-94, 1995 Mar-Apr.

Sterling RC. Gottheil E. Weinstein SP. Kurtz JW. Menduke H. The effect of a no-smoking policy on recruitment and retention in outpatient cocaine treatment. Journal of Addictive Diseases. 13(4):161-8, 1994.

Biological Aspects of Addiction Psychiatry: Nicotine (Sessions 8-9)
a.    Nicotine use disorders: Dependence, withdrawal states, with a focus on phenomenology
and neurobiology.

1. Benowitz N.L. Clinical pharmacology of inhaled drugs of abuse: implications in understanding nicotine dependence. NIDA Research monograph. 99:12, 1990.
2. Benowits N.L., Jacob P. Nicotine and Cotinine elimination pharmacokinetics in smokers and nonsmokers. Clin Pharmacol Ther. 53:316-23, 1993.

b. Medical complications of Nicotine use: CNS, CBs, Obstetrical, RS, GI, ID, endocrinological aspects.

1. Perkins K.A. Metabolic effects of cigarette smoking. J Appl Phys 72:401-09, 1992.
2. Waldum H.L., Nilsen O.G. Long-term effects of inhaled nicotine. Life Sciences. 58:1339-46, 1996.
3. Anonymous. Cigarette smoking and health. Amer J of Resp & Critical Care Med.

c. Pharmacology: Absorption, metabolism, pharmacokinetic-dynamics & co-administration with other substances.

1. Benowitz N.L. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 319:1318-30, 1988.
2. Benowitz N.L. Clinical pharmacology of nicotine. Ann Rev Med 37:21-32, 1986.

d. Pharmacotherapy: Treatment options and the debates

1. Hughes J.R. Pharmacotherapy for smoking cessation: unvalidated assumptions, anomalies and suggestions for future research. J Consult Clin Psychol. 61:751-60, 1993.
2. Hughes J.R. Treatment of nicotine dependence: Is more better? JAMA. 274:1390-91, 1995.
3. Hillemann D.E., Mohiuddin S.M., Del Core M.G., Sketch M.H. Effect of buspironeon withdrawal symptoms associated with smoking cessation. Arch Intern Med. 152:350-52, 1992.
4. Edwards N.B., Murphy J.K., Downs A.D., etc al. Doxepin as an adjunct to smoking cessation: a double-blind pilot study. Am J Psychiatry 146:373-76, 1989.

e. Psvchopathology Implications for dual diagnosis treatment

1. Newhouse P.A., Hughes J.R. The role of nicotine and nicotinic mechanisms in neuropsychiatric disease. Br. Jr Addict. 86:521, 1991.
2. Glassman A.H. Cigarette smoking: implication for psychiatric illness. Am. J. Psychiatry. 150:546-53, 1993.
3. Cardoni A.A. Psychopharmacology of nicotine: implications for pharmacotherapy in psychiatry. Conn. Med. 57:15-17, 1993.

Bibliography

American Psychiatric Association. American Psychiatric Association Practice Guideline For the Treatment of Nicotine Dependence. American Journal of Psychiatry, 154: Supplement to October, 1996 issue.

American Psychiatric Association. Nicotine Dependence Task Force Position Statement on Nicotine Dependence. American Journal of Psychiatry, 152:481, 1995.

Brown, R. A., Goldstein, M. G., Niaura, R., Emmons, K. E., & Abrams, D. B. Nicotine Dependence: Assessment and Management In A. Stoudemire & B. S. Fogel (Eds.), Principles of Medical Psychiatry, Second Edition, pp. 877-901, 1993.

Hughes, J.R. Possible Effects of Smoke-free Inpatient Units on Psychiatric Diagnosis and Treatment. Journal of Clinical Psychiatry, 54:109-114,1993.

Hughes, J.R. Clinical Implications of the Association Between Smoking and Alcoholism. In: Alcohol and Tobacco: From Basic Science to Policy, NIAAA Research Monograph 30, edited by Fertig, J. and Fuller, R. Washington: U.S. Government Printing Office, pp. 171-185, 1996.

Links
APA Online Nicotine Dependence

Bibliographies   Resource Listing by Subject   PGY-V Home